Search

Author/Creator Leszczyński, Piotr

1. 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. (19th August 2017)

Authors:
Emery, Paul; Vencovský, Jiří; Sylwestrzak, Anna; Leszczyński, Piotr; Porawska, Wieslawa; Baranauskaite, Asta; Tseluyko, Vira; Zhdan, Vyacheslav M.; Stasiuk, Barbara; Milasiene, Roma; Barrera Rodriguez, Aaron Alejandro; Cheong, Soo Yeon; Ghil, Jeehoon
Journal:
Rheumatology
Issue:
Volume 56:Number 12(2017)
Page Start:
2093
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Issue 1 (6th July 2015)

Authors:
Emery, Paul; Vencovský, Jiří; Sylwestrzak, Anna; Leszczyński, Piotr; Porawska, Wieslawa; Baranauskaite, Asta; Tseluyko, Vira; Zhdan, Vyacheslav M; Stasiuk, Barbara; Milasiene, Roma; Barrera Rodriguez, Aaron Alejandro; Cheong, Soo Yeon; Ghil, Jeehoon
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 1(2017)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis. (18th July 2018)

Authors:
Genovese, Mark C; Weinblatt, Michael E; Mease, Philip J; Aelion, Jacob A; Peloso, Paul M; Chen, Kun; Li, Yihan; Liu, John; Othman, Ahmed A; Khatri, Amit; Mansikka, Heikki T; Leszczyński, Piotr
Journal:
Rheumatology
Issue:
Volume 57:Number 11(2018)
Page Start:
1972
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Issue 2 (28th January 2017)

Authors:
Clowse, Megan E. B.; Wallace, Daniel J.; Furie, Richard A.; Petri, Michelle A.; Pike, Marilyn C.; Leszczyński, Piotr; Neuwelt, C. Michael; Hobbs, Kathryn; Keiserman, Mauro; Duca, Liliana; Kalunian, Kenneth C.; Galateanu, Catrinel; Bongardt, Sabine; Stach, Christian; Beaudot, Carolyn; Kilgallen, B...
Other Names:
Batalov A. investigator.; Bojinca M. investigator.; Djerassi R. investigator.; Duca L. investigator.; Horak P. investigator.; Kolarov Z. investigator.; Milasiene R. investigator.; Monova D. investigator.; Otsa K. investigator.; Pileckyte M. investigator.; Popova T. investigator.; Radulescu F. inv...
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Issue 2 (February 2017)

Authors:
Clowse, Megan E. B.; Wallace, Daniel J.; Furie, Richard A.; Petri, Michelle A.; Pike, Marilyn C.; Leszczyński, Piotr; Neuwelt, C. Michael; Hobbs, Kathryn; Keiserman, Mauro; Duca, Liliana; Kalunian, Kenneth C.; Galateanu, Catrinel; Bongardt, Sabine; Stach, Christian; Beaudot, Carolyn; Kilgallen, B...
Other Names:
Batalov A. investigator.; Bojinca M. investigator.; Djerassi R. investigator.; Duca L. investigator.; Horak P. investigator.; Kolarov Z. investigator.; Milasiene R. investigator.; Monova D. investigator.; Otsa K. investigator.; Pileckyte M. investigator.; Popova T. investigator.; Radulescu F. inv...
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4. Issue 12 (9th August 2017)

Authors:
Emery, Paul; Vencovský, Jiří; Sylwestrzak, Anna; Leszczyński, Piotr; Porawska, Wieslawa; Stasiuk, Barbara; Hilt, Joanna; Mosterova, Zdenka; Cheong, Soo Yeon; Ghil, Jeehoon
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 12(2017)
Page Start:
1986
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. (6th May 2021)

Authors:
Furie, Richard A; Bruce, Ian N; Dörner, Thomas; Leon, Manuel Gustavo; Leszczyński, Piotr; Urowitz, Murray; Haier, Birgit; Jimenez, Teri; Brittain, Claire; Liu, Jiajun; Barbey, Catherine; Stach, Christian
Journal:
Rheumatology
Issue:
Volume 60:Number 11(2021)
Page Start:
5397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗